Fluorine in PDB 4uxq: FGFR4 in Complex with Ponatinib
Enzymatic activity of FGFR4 in Complex with Ponatinib
All present enzymatic activity of FGFR4 in Complex with Ponatinib:
2.7.10.1;
Protein crystallography data
The structure of FGFR4 in Complex with Ponatinib, PDB code: 4uxq
was solved by
J.Tucker,
T.Klein,
J.Breed,
A.Breeze,
R.Overman,
C.Phillips,
R.A.Norman,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
20.00 /
1.85
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
41.835,
58.371,
60.570,
90.00,
96.48,
90.00
|
R / Rfree (%)
|
20.14 /
26.81
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the FGFR4 in Complex with Ponatinib
(pdb code 4uxq). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
FGFR4 in Complex with Ponatinib, PDB code: 4uxq:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 4uxq
Go back to
Fluorine Binding Sites List in 4uxq
Fluorine binding site 1 out
of 3 in the FGFR4 in Complex with Ponatinib
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of FGFR4 in Complex with Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1752
b:17.5
occ:1.00
|
F1
|
A:0LI1752
|
0.0
|
17.5
|
1.0
|
C19
|
A:0LI1752
|
1.4
|
17.8
|
1.0
|
F3
|
A:0LI1752
|
2.1
|
17.9
|
1.0
|
F2
|
A:0LI1752
|
2.2
|
14.4
|
1.0
|
C17
|
A:0LI1752
|
2.4
|
19.3
|
1.0
|
C18
|
A:0LI1752
|
2.7
|
19.9
|
1.0
|
O
|
A:ILE628
|
2.9
|
13.7
|
1.0
|
CA
|
A:ALA629
|
3.4
|
11.3
|
1.0
|
C
|
A:ILE628
|
3.4
|
15.1
|
1.0
|
CG2
|
A:ILE534
|
3.6
|
22.3
|
1.0
|
N
|
A:ALA629
|
3.6
|
12.5
|
1.0
|
C16
|
A:0LI1752
|
3.7
|
19.9
|
1.0
|
C
|
A:ALA629
|
3.7
|
15.2
|
1.0
|
O
|
A:ALA629
|
4.1
|
14.7
|
1.0
|
C13
|
A:0LI1752
|
4.1
|
18.9
|
1.0
|
CG2
|
A:ILE628
|
4.2
|
18.5
|
1.0
|
N
|
A:ASP630
|
4.3
|
11.4
|
1.0
|
C20
|
A:0LI1752
|
4.3
|
21.0
|
1.0
|
N
|
A:ILE534
|
4.5
|
19.5
|
1.0
|
CB
|
A:ILE628
|
4.5
|
16.6
|
1.0
|
O1
|
A:0LI1752
|
4.6
|
23.4
|
1.0
|
CA
|
A:ILE628
|
4.6
|
13.1
|
1.0
|
CD1
|
A:ILE527
|
4.7
|
32.5
|
1.0
|
CB
|
A:ILE534
|
4.7
|
21.3
|
1.0
|
CB
|
A:ALA629
|
4.8
|
11.3
|
1.0
|
CB
|
A:ILE533
|
4.8
|
23.0
|
1.0
|
C15
|
A:0LI1752
|
4.8
|
19.7
|
1.0
|
N2
|
A:0LI1752
|
4.9
|
19.3
|
1.0
|
C14
|
A:0LI1752
|
4.9
|
16.8
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 4uxq
Go back to
Fluorine Binding Sites List in 4uxq
Fluorine binding site 2 out
of 3 in the FGFR4 in Complex with Ponatinib
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of FGFR4 in Complex with Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1752
b:14.4
occ:1.00
|
F2
|
A:0LI1752
|
0.0
|
14.4
|
1.0
|
C19
|
A:0LI1752
|
1.4
|
17.8
|
1.0
|
F3
|
A:0LI1752
|
2.2
|
17.9
|
1.0
|
F1
|
A:0LI1752
|
2.2
|
17.5
|
1.0
|
C17
|
A:0LI1752
|
2.4
|
19.3
|
1.0
|
C20
|
A:0LI1752
|
3.0
|
21.0
|
1.0
|
C16
|
A:0LI1752
|
3.1
|
19.9
|
1.0
|
CD1
|
A:ILE527
|
3.4
|
32.5
|
1.0
|
C18
|
A:0LI1752
|
3.5
|
19.9
|
1.0
|
CD2
|
A:LEU603
|
3.8
|
20.2
|
1.0
|
CG2
|
A:ILE527
|
4.1
|
30.0
|
1.0
|
CG1
|
A:ILE527
|
4.3
|
30.6
|
1.0
|
C15
|
A:0LI1752
|
4.4
|
19.7
|
1.0
|
N3
|
A:0LI1752
|
4.4
|
18.1
|
1.0
|
CD1
|
A:LEU603
|
4.5
|
16.0
|
1.0
|
C13
|
A:0LI1752
|
4.7
|
18.9
|
1.0
|
CG
|
A:LEU603
|
4.8
|
17.4
|
1.0
|
O
|
A:ILE628
|
4.8
|
13.7
|
1.0
|
SG
|
A:CYS608
|
4.9
|
26.8
|
1.0
|
CB
|
A:ILE527
|
4.9
|
29.6
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 4uxq
Go back to
Fluorine Binding Sites List in 4uxq
Fluorine binding site 3 out
of 3 in the FGFR4 in Complex with Ponatinib
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of FGFR4 in Complex with Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1752
b:17.9
occ:1.00
|
F3
|
A:0LI1752
|
0.0
|
17.9
|
1.0
|
C19
|
A:0LI1752
|
1.4
|
17.8
|
1.0
|
F1
|
A:0LI1752
|
2.1
|
17.5
|
1.0
|
F2
|
A:0LI1752
|
2.2
|
14.4
|
1.0
|
C17
|
A:0LI1752
|
2.4
|
19.3
|
1.0
|
C16
|
A:0LI1752
|
3.1
|
19.9
|
1.0
|
C20
|
A:0LI1752
|
3.1
|
21.0
|
1.0
|
C18
|
A:0LI1752
|
3.4
|
19.9
|
1.0
|
CD2
|
A:HIS610
|
3.5
|
16.0
|
1.0
|
NE2
|
A:HIS610
|
3.5
|
15.8
|
1.0
|
O
|
A:ALA629
|
3.6
|
14.7
|
1.0
|
C
|
A:ALA629
|
3.8
|
15.2
|
1.0
|
CG2
|
A:ILE628
|
3.8
|
18.5
|
1.0
|
CB
|
A:ASP630
|
4.0
|
12.2
|
1.0
|
C21
|
A:0LI1752
|
4.2
|
16.7
|
1.0
|
N3
|
A:0LI1752
|
4.2
|
18.1
|
1.0
|
CA
|
A:ALA629
|
4.3
|
11.3
|
1.0
|
N
|
A:ASP630
|
4.3
|
11.4
|
1.0
|
C15
|
A:0LI1752
|
4.3
|
19.7
|
1.0
|
CD1
|
A:LEU603
|
4.4
|
16.0
|
1.0
|
N
|
A:ALA629
|
4.4
|
12.5
|
1.0
|
O
|
A:ILE628
|
4.5
|
13.7
|
1.0
|
C
|
A:ILE628
|
4.5
|
15.1
|
1.0
|
CE1
|
A:HIS610
|
4.5
|
15.6
|
1.0
|
CG
|
A:HIS610
|
4.6
|
14.7
|
1.0
|
C13
|
A:0LI1752
|
4.6
|
18.9
|
1.0
|
CA
|
A:ASP630
|
4.7
|
11.4
|
1.0
|
CB
|
A:ILE628
|
4.8
|
16.6
|
1.0
|
CD2
|
A:LEU603
|
4.9
|
20.2
|
1.0
|
C14
|
A:0LI1752
|
5.0
|
16.8
|
1.0
|
|
Reference:
J.Tucker,
T.Klein,
J.Breed,
A.Breeze,
R.Overman,
C.Phillips,
R.A.Norman.
Structural Insights Into Fgfr Kinase Isoform Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib with FGFR1 and FGFR4 To Be Published.
Page generated: Thu Aug 1 06:15:10 2024
|